Investigates how APOE and low-density-lipoprotein receptor pathways regulate amyloid metabolism and Alzheimer's disease pathogenesis. Studies LDL receptor trafficking and degradation, apoE-targeted interventions, and microRNA-based biomarkers that may support diagnosis or therapy.